SEC Form 4 · accession 0001600132-17-000067
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jens Luehring
Director · 10% Owner
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 6:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 28, 2017 | A | 30,798 | $0.00 | A | 70,658 | D |
Table II — derivative securities
No Table II lines on this filing.